C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease
- PMID: 11034902
- DOI: 10.1242/jcs.113.21.3737
C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is, in part, defined by the polymerization of tau into paired helical and straight filaments (PHF/SFs) which together comprise the fibrillar pathology in degenerating brain regions. Much of the tau in these filaments is modified by phosphorylation. Additionally, a subset also appears to be proteolytically truncated, resulting in the removal of its C terminus. Antibodies that recognize tau phosphorylated at S(396/404 )or truncated at E(391) do not stain control brains but do stain brain sections very early in the disease process. We modeled these phosphorylation and truncation events by creating pseudo-phosphorylation and deletion mutants derived from a full-length recombinant human tau protein isoform (ht40) that contains N-terminal exons 2 and 3 and all four microtubule-binding repeats. In vitro assembly experiments demonstrate that both modifications greatly enhance the rates of tau filament formation and that truncation increases the mass of polymer formed, as well. Removal of as few as 12 or as many as 121 amino acids from the C terminus of tau greatly increases the rate and extent of tau polymerization. However, deletion of an additional 7 amino acids, (314)DLSKVTS(320), from the third microtubule-binding repeat results in the loss of tau's ability to form filaments in vitro. These results suggest that only part of the microtubule-binding domain (repeats 1, 2 and a small portion of 3) is crucial for tau polymerization. Moreover, the C terminus of tau clearly inhibits the assembly process; this inhibition can be partially reversed by site-specific phosphorylation and completely removed by truncation events at various sites from S(320) to the end of the molecule.
Similar articles
-
Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein.Microsc Res Tech. 2005 Jul;67(3-4):156-63. doi: 10.1002/jemt.20195. Microsc Res Tech. 2005. PMID: 16104002 Review.
-
Posttranslational modifications of tau in paired helical filaments.Dementia. 1994 Sep-Oct;5(5):282-8. doi: 10.1159/000106736. Dementia. 1994. PMID: 7951685 Review.
-
Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.Mol Neurobiol. 1991;5(2-4):399-410. doi: 10.1007/BF02935561. Mol Neurobiol. 1991. PMID: 1726645 Review.
-
Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.Biochemistry. 1999 Mar 23;38(12):3549-58. doi: 10.1021/bi981874p. Biochemistry. 1999. PMID: 10090741
-
Oxidized and phosphorylated synthetic peptides corresponding to the second and third tubulin-binding repeats of the tau protein reveal structural features of paired helical filament assembly.J Pept Res. 1997 Aug;50(2):132-42. doi: 10.1111/j.1399-3011.1997.tb01178.x. J Pept Res. 1997. PMID: 9273897
Cited by
-
Cellular and pathological functions of tau.Nat Rev Mol Cell Biol. 2024 Nov;25(11):845-864. doi: 10.1038/s41580-024-00753-9. Epub 2024 Jul 16. Nat Rev Mol Cell Biol. 2024. PMID: 39014245 Review.
-
Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties.Proc Natl Acad Sci U S A. 2022 Sep 13;119(37):e2204179119. doi: 10.1073/pnas.2204179119. Epub 2022 Sep 6. Proc Natl Acad Sci U S A. 2022. PMID: 36067305 Free PMC article.
-
In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease.Cerebellum. 2003;2(4):270-8. doi: 10.1080/14734220310004289. Cerebellum. 2003. PMID: 14964686 Review.
-
Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro.Biochemistry. 2009 Dec 29;48(51):12290-7. doi: 10.1021/bi901304u. Biochemistry. 2009. PMID: 19919107 Free PMC article.
-
Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice.Oncotarget. 2015 Oct 27;6(33):34128-42. doi: 10.18632/oncotarget.6021. Oncotarget. 2015. PMID: 26452037 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical